Coreceptor expression is tightly regulated during thymocyte development. Deletion of specific Cd8 enhancers leads to variegated expression of CD8ab heterodimers in double-positive thymocytes. Here we show CD8 variegation is correlated with an epigenetic 'off' state, linking Cd8 enhancer function with chromatin remodeling of the adjacent genes Cd8a and Cd8b1 (Cd8 ). The zinc finger protein MAZR bound the Cd8 enhancer and interacted with the nuclear receptor corepressor N-CoR complex in doublenegative thymocytes. MAZR was downregulated in double-positive and CD8 single-positive thymocytes. 'Enforced' expression of MAZR led to impaired Cd8 activation and variegated CD8 expression. Our results demonstrate epigenetic control of the Cd8 loci and identify MAZR as an important regulator of Cd8 expression.
Cell fate specification during T lymphocyte differentiation is linked with spatial and temporal control of the expression of developmentally regulated genes 1 . Epigenetic modifications are an important level of regulatory control of gene expression 2, 3 . Cd4 and Cd8 (Cd8a and Cd8b1) coreceptor gene expression has also been suggested to be epigenetically regulated 4 . For CD4, a T cell-specific enhancer located 13 kilobases upstream of the Cd4 promoter directs expression in both helper and cytotoxic T cells 5 , whereas a silencer element located in the first intron of Cd4 provides subset specificity by silencing transcription of Cd4 in double-negative (DN) thymocytes and mature CD8 + T cells [6] [7] [8] . Conditional gene targeting in mice has shown that the silencer element is required for the establishment but not the maintenance of Cd4 silencing, suggesting that silencing of CD4 expression in mature CD8 + T cells is regulated at the epigenetic level 9, 10 .
For CD8 (usually consisting of CD8a and CD8b heterodimers on thymic-derived T cells), at least five distinct Cd8 cis-acting elements (enhancers E8 I -E8 V ) that individually or in combination direct expression in the T cell lineage have been identified in transgenic reporter expression assays 11 . Those studies indicate that a complex regulatory network of developmental stage-and subset-specific cis-regulatory elements is needed to achieve proper expression of the linked Cd8a and Cd8b1 genes during T cell development. For analysis of the various cis elements in more detail, mice with single and combinatorial germline deletion analysis of enhancers have been generated [12] [13] [14] [15] . Individual deletion of either E8 I or E8 II does not alter the expression pattern of CD8 during T cell development, whereas deletion of both E8 I and E8 II impairs the expression of CD8 in double-positive (DP) thymocytes 14 . Germline deletion of E8 I and E8 II leads to the appearance of a population of CD4 singlepositive (SP) cells with a low-to-intermediate CD3 (CD3 lo ) and intermediate CD5 (CD5 int ) surface expression phenotype characteristic of DP thymocytes 14 . These cells are indistinguishable from other DP thymocytes by the expression of other surface markers or functional phenotype and represent DP thymocytes that fail to express CD8; therefore, we refer to them here as 'CD8 -DP' cells. The concurrent appearance of CD8 -DP thymocytes in addition to true DP cells indicates variegation of CD8 expression in the absence of E8 I and E8 II . A similar phenotype is obtained by deletion of the Cd8 cis element designated cluster II (E8 V ), by the combined deletion of E8 II and E8 III or by alteration of the activity of either the BAF chromatinremodeling complex or members of the Ikaros family of transcriptional regulators [15] [16] [17] [18] . Those results collectively suggest that expression of Cd8a and Cd8b1 is epigenetically regulated and that some of the Cd8 cis-regulatory elements may function as recruitment sites for factors involved in chromatin remodeling to facilitate activation of the Cd8a and Cd8b1 loci during the DN-to-DP transition of T cell development.
To investigate whether deletion of E8 I and E8 II leads to a change in chromatin remodeling during T cell development, we have compared the epigenetic state of the Cd8a and Cd8b1 loci in sorted CD8 -DP thymocytes and true DP thymocytes isolated from mice doubly deficient in E8 I and E8 II . Chromatin immunoprecipitation assay and DNA methylation analysis showed that CD8 -DP thymocytes had epigenetic modifications at the Cd8a-Cd8b1 complex that corresponded to an 'off' state of chromatin. Variegation of CD8 expression in DP thymocytes could be partially reverted by intercross of mice doubly deficient in E8 I and E8 II with mice with conditional deficiency in DNA methyltransferase 1 (Dnmt1) 19 , further indicating a partial 'epigenetic block' of CD8 expression due to the absence of cis-regulatory elements. To study the molecular basis of the epigenetic regulation of CD8 expression in more detail, we searched for factors that bind to enhancer E8 II . Yeast one-hybrid screening approaches led to isolation of the zinc finger transcription factor MAZR (Myc-associated zinc finger-related factor 20 ). MAZR was highly expressed in DN thymocytes, and its expression was downmodulated with progressive thymocyte differentiation. Cd8 enhancers recruited MAZR to the Cd8 loci. MAZR interacted via its N-terminal domain, which contains a BTB-POZ motif (brica-bric, tramtrack, broad complex; poxvirus zinc finger) with nuclear receptor corepressor N-CoR complexes in DN thymocytes. Retrovirus-mediated constitutive expression of MAZR during T cell development unexpectedly resulted in variegated expression of CD8 in DP thymocytes, suggesting that MAZR negatively regulates chromatin modification at the Cd8 loci required for the activation of CD8 expression. Thus, our results show that CD8 expression is regulated at the epigenetic level and indicate that CD8 expression is actively repressed at the DN stage. Furthermore, they indicate that Cd8 enhancers have the potential to function as both negative and positive cis-acting elements by recruiting factors that block or facilitate, respectively, chromatin modifications required for a transcriptional 'on' state.
RESULTS
Epigenetic changes in mice doubly deficient in E8 I and E8 II As described above, germline deletion of E8 I and E8 II leads to the appearance of a population of CD4 SP cells with a CD3 lo CD5 int surface expression phenotype characteristic of DP thymocytes 14 , called 'CD8 -DP' cells here. In parallel with the appearance of CD8 -DP cells, the percentage of true DP cells is reduced. Those results demonstrate variegated expression of CD8 in DP thymocytes and indicate epigenetic regulation of the Cd8 gene complex. They also suggest that E8 I and E8 II may serve as recruitment sites for chromatin-modifying factors during the DN-to-DP transition of thymocyte development. To investigate whether E8 I and E8 II function as recruitment elements, we analyzed epigenetic modifications at the Cd8a-Cd8b1 complex in CD8-expressing and CD8 -DP thymocytes in mice doubly deficient in E8 I and E8 II . To obtain a pure population of CD8 -DP thymocytes devoid of any mature CD4 SP thymocytes for chromatin immunoprecipitation experiments, we used thymocytes from mice doubly deficient for E8 I and E8 II backcrossed onto a T cell receptor-adeficient background (E8 I ,E8 II -KO Â Tcra -/-mice 14 ; Fig. 1a) . We isolated CD8 -and true DP thymocytes and analyzed the cells by chromatin immunoprecipitation for differences in histone modification, including H3 and H4 acetylation and H3 lysine 4 (H3K4) trimethylation at several regions in Cd8 loci. The nonexpressing Cd8 alleles had less H3 and H4 acetylation than the expressing Cd8 alleles at all amplicons analyzed (Fig. 1b) . In contrast, the abundance of acetylated H3 and H4 was not reduced at the Cd4 promoter or glyceraldehyde phosphate dehydrogenase gene regions. A similar correlation has also been noted for the Cd8a and Cd8b1 promoter regions with respect to H3K4 trimethylation, a modification associated with promoters of transcriptionally active genes 21 . We also did chromatin immunoprecipitation assays using antibodies to dimethylated or trimethylated histone H3K9, a histone modification associated with transcriptionally inactive chromatin 22 . However, we found that no fragments specific for the Cd8a-Cd8b1 complex could be precipitated, indicating that H3K9 methylation is not involved in the 
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Cluster III Cluster II regulation of CD8 expression during the DN-to-DP transition (data not shown).
As thymocytes develop from the DN stage to the DP stage, progressive CpG demethylation of DNA at the Cd8 loci occurs concomitantly with the initiation of coreceptor expression 23, 24 . That finding suggests that CpG demethylation is one of the epigenetic changes required for (or correlating with) the proper initiation of CD8 expression. To determine whether expressing and nonexpressing Cd8 alleles have differences in CpG methylation, we isolated DNA from CD8 -and true DP thymocytes from E8 I ,E8 II -KO Â Tcra -/-mice. We assayed DNA methylation by treating the DNA with sodium bisulfite followed by PCR amplification, as described 19 . Although CD8-expressing DP thymocytes contained clusters of nonmethylated CpG dinucleotides upstream of the Cd8a and Cd8b1 promoterproximal regions, the respective CpG clusters were almost completely methylated in CD8 -DP thymocytes (Fig. 2) .
Loss of Dnmt1 leads to partial reactivation of CD8
To investigate whether the failure to activate the Cd8 loci properly in CD8 -DP thymocytes from mice doubly deficient in E8 I and E8 II was caused by sustained CpG methylation of the Cd8a-Cd8b1 complex, we intercrossed mice doubly deficient in E8 I and E8 II with mice with conditional deletion of conditional Dnmt1. The latter mice have a loxP-flanked Dnmt1 and express Cre recombinase under control of the tissue-specific Lck proximal promoter, which becomes active early at the DN2 stage of thymocyte development 19 . Deletion of Dnmt1 in DN thymocytes partially 'rescued' the variegated expression phenotype of mice doubly deficient in E8 I and E8 II , as demonstrated by a reduction in CD8 -DP cells ( Supplementary Fig. 1 online) . This result emphasizes the involvement of Cd8 enhancers in mediating Cd8 loci-specific chromatin modifications.
MAZR binds to E8 II in vivo
The results described above indicated that E8 I and E8 II may serve as recruitment sites for factors that regulate chromatin. By using a combination of bioinformatics approaches and luciferase reporter gene transactivation assays, we identified a 154-base pair E8 II core enhancer containing two regulatory elements in the 4.4-kilobase genomic E8 II fragment (I.B. and W.E., unpublished data). Deletion of regulatory element 1 (RE-1; nucleotides 123-154) resulted in a complete loss of enhancer activity (data not shown). Yeast one-hybrid screens using RE-1 as 'bait' and a cDNA fusion library of the 1200M mouse thymoma cell line with the Gal4 activation domain as 'prey' led to the isolation of a cDNA fragment encoding MAZR (641 amino acids in length). In addition to an N-terminal BTB domain, MAZR contains seven C 2 H 2 zinc fingers 20 . The yeast one-hybrid screen clone insert encoded the first 409 amino acids, including the BTB domain and three complete zinc finger domains ( Supplementary Fig. 2 online). MAZR binds to guanine-rich sequences 20 , which were also present in RE-1 ( Supplementary Fig. 2 online) . We confirmed binding of MAZR to RE-1 in vitro by electrophoretic mobility-shift assay using a 5¢ Myc-tagged version of MAZR (Fig. 3a) .
To determine whether MAZR binds also to E8 II in vivo, we used chromatin immunoprecipitation. We generated polyclonal rabbit antibodies to a fusion protein of glutathione S-transferase and amino acids 146-293 of MAZR (anti-MAZR serum specificity, Supplementary Fig. 3 online). As MAZR expression was highest in DN thymocytes (discussed below), we used anti-MAZR serum to immunoprecipitate MAZR-DNA complexes from formaldehydetreated DN thymocytes. Precipitation of MAZR-DNA complexes with anti-MAZR serum led to selective enrichment of E8 II sequences, in contrast to no enrichment after precipitation with preimmune serum, indicating in vivo binding of MAZR to E8 II (Fig. 3b) .
Downregulation of MAZR during T cell development
MAZR is expressed in many tissues, including fetal liver, bone marrow and thymus 20 . To determine the expression pattern of MAZR in various thymocyte subsets, we used real-time quantitative PCR analysis and immunoblot analysis of sorted DN, DP, CD8 SP and CD4 SP thymocyte populations. DN thymocytes had more expression Cluster II
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CD8 -DP B Figure 2 DNA methylation of the promoter, exon and intron regions of Cd8a and Cd8b1. Genomic DNA from DP and CD8 -DP thymocytes was treated with sodium bisulfite and was amplified by PCR 23, 24 . Positions (above methylation data) are relative to the initiation codon. Individual PCR products were cloned and sequenced; each row of circles represents one clone. Four clones of each of three independently prepared thymocytes for each group were sequenced. Open circles, unmethylated CpG sites; filled circles, methylated CpG sites. of MAZR than did DP cells (Fig. 3c,d ). CD8 SP thymocytes had even less MAZR expression. We detected almost no MAZR expression in peripheral T cells (Fig. 3d) .
MAZR induces variegation of CD8 expression MAZR was originally isolated as a protein interacting with the B cell and neuronal transcriptional repressor Bach2. MAZR can also transactivate the Myc and Fgf4 promoters in transient reporter expression assays 20 . As MAZR interacted with E8 II , we investigated whether it regulates Cd8a and Cd8b1 expression. We expressed MAZR ectopically in thymocytes using retrovirus-mediated gene transduction of hematopoietic stem cells followed by bone marrow transplantation into irradiated recipients (constructs, Supplementary Fig. 4 online). All the retroviral constructs contained an internal ribosomal entry site followed by the green fluorescent protein (GFP) to distinguish between transduced and nontransduced thymocytes. 'Enforced' expression of MAZR resulted in a small increase in the percentage of CD4 SP thymocytes, leading to an increase of approximately twofold in the CD4/CD8 ratios in GFP + thymocytes versus GFP -thymocytes (2.0 ± 0.7; n ¼ 5; Fig. 4a and data not shown). In contrast, GFP + thymocytes transduced with the 'parental' MIG-R vector had no increase in the percentage that were CD4 SP, resulting in similar CD4/CD8 ratios in GFP + and GFP -thymocytes (1.1 ± 0.1; n ¼ 5).
To investigate the increase in the percentage of CD4 SP thymocytes in more detail, we determined the developmental stage of MAZRtransduced CD4 SP cells. Mature CD4 SP thymocytes have high surface expression of CD3 and CD5, whereas immature DP thymocytes are CD3 lo CD5 int (ref. 25 ), a phenotype we also noted in MIG-Rtransduced CD4 SP and DP thymocytes (Fig. 4b) . In contrast, the GFP + CD4 SP population had two distinct cell subsets for thymocytes expressing MAZR constitutively. In addition to mature CD3 hi CD5 hi CD4 SP cells, we detected a CD3 lo CD5 int CD4 + CD8 -subset in all mice reconstituted with MAZR-transduced bone marrow (Figs. 4b and  5a, left) . Furthermore, CD4 + CD3 lo cells developed in chimeric recombination-activating gene-deficient mice reconstituted with MAZR-transduced Tcra -/-bone marrow ( Supplementary Fig. 5 online). That finding suggests that these cells develop before the onset of positive selection. The appearance of the CD8 -DP subset was more prominent with gating only on cells with high expression of GFP, which correlated with higher MAZR expression (Fig. 5a) . That result demonstrated a dose-dependent influence of MAZR on the expression of CD8. The phenotype of MAZR-expressing thymocytes is thus reminiscent of the CD8 variegation phenotype noted in mice doubly deficient in E8 I and E8 II or in mice deficient in cluster II (E8 V ), thus linking MAZR to the regulation of CD8 expression.
Variegation of CD8 in the absence of E8 I or E8 II Enforced expression of MAZR might negatively regulate Cd8a and Cd8b1 expression through interaction with E8 II . In contrast to combined deletions, deletion of either E8 I or E8 II alone has only a marginal effect on the expression of CD8 during thymocyte development [12] [13] [14] . Thus, a potential repressive function of MAZR acting at E8 II could be counterbalanced by compensatory factors acting at E8 I . To test that possibility, we transduced E8 I -deficient bone marrow cells with MAZR-expressing retrovirus and transplanted the cells into irradiated E8 I -deficient mice. The percentage of CD8 -DP thymocytes (CD4 + CD3 lo CD5 int ) after enforced MAZR expression increased much more in E8 I -deficient thymocytes than in wild-type thymocytes (Fig. 5a, middle) . To confirm that the increased CD4 + CD3 lo cells in MAZR-transduced E8 I -deficient bone marrow-chimeric mice had a DP phenotype (and were not mature CD4 SP thymocytes that for unknown reasons were CD3 lo and CD5 int ), we sorted CD4 + CD3 lo , DP and CD4 + CD3 hi cells and assessed expression of the zinc finger transcription factor Th-POK (also called cKrox). Th-POK is induced in developing CD4 SP thymocytes after T cell receptor stimulation of DP cells and is a 'master regulator' of CD4 lineage differentiation 26, 27 . Although Th-POK was expressed in CD4 + CD3 hi cells, it was not expressed in DP or in CD4 + CD3 lo cells (Fig. 5b) . This finding indicated that the CD4 + CD3 lo cells were not mature CD4 SP cells and thus demonstrated again the presence of CD8 -DP cells after enforced expression of MAZR.
To determine whether E8 II is the only recruitment site and therefore is required for MAZR function, we transduced E8 II -deficient bone marrow cells with MAZR retrovirus and transplanted the cells into irradiated E8 II -deficient mice. There was also increased variegation after enforced expression of MAZR in E8 II -deficient thymocytes (Fig. 5a, right) . This finding indicates that in addition to E8 II , other Cd8 cis-regulatory elements were able to recruit MAZR to the Cd8a-Cd8b1 complex.
Multiple MAZR binding sites at the Cd8 loci Nucleotide sequence analysis based on the MAZR-binding motif in E8 II RE-1 and the published MAZR consensus binding site demonstrated at least eleven additional potential binding sites in the five known Cd8 cisregulatory elements. We used chromatin immunoprecipitation to determine whether MAZR interacts with these sites. Precipitation of MAZR-DNA complexes from DN thymocytes using polyclonal rabbit anti-mouse MAZR serum led to selective enrichment of at least seven of the eleven PCR fragments containing the binding sites, compared with mock precipitation with preimmune serum (Fig. 6a) . In contrast, there was no selective enrichment of control PCR fragments without MAZR binding sites detected, when compared to mock precipitation (Fig. 6a) . Thus, MAZR is recruited to multiple sites in the Cd8 loci in DN thymocytes. To test whether MAZR was recruited to these sites in DP cells, we did comparative chromatin immunoprecipitation experiments with DN and DP thymocytes. At least four of the seven amplicons were less amplified in DP thymocytes than in DN cells, indicating reduced MAZR binding at the Cd8a-Cd8b1 complex in DP cells (Fig. 6b ).
MAZR interacts with the N-CoR corepressor
The BTB domains of most known transcription factors are able to interact with N-CoR and/or SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressors [28] [29] [30] [31] . This interaction depends on critical conserved amino acid residues 28, 31 that are also present in the BTB domain of MAZR ( Supplementary Fig. 4 online). To test whether the BTB domain of MAZR interacts with N-CoR as well, we did coimmunoprecipitation experiments. We transfected HEK293T cells with N-CoR and either wild-type MAZR or a mutant form of MAZR (MAZR mut ) containing point mutations in the sequence encoding conserved amino acid residues of the BTB domain required for corepressor interaction 28 . MAZR interacted with N-CoR in a BTB domain-dependent way, as only wild-type but not MAZR mut immunoprecipitated together with N-CoR (Fig. 7a) . More notably, there was also interaction between MAZR and N-CoR in primary DN thymocytes (Fig. 7b) . Thus, these findings indicate a possible molecular mechanism by which MAZR negatively regulates the expression of CD8.
The BTB domain alone does not induce CD8 variegation MAZR binds to E8 II and other Cd8 cis-regulatory elements, suggesting direct regulation of CD8 expression. However, enforced expression of MAZR could also sequester endogenous factors from the Cd8a-Cd8b1 complex, resulting in an indirect influence of MAZR on CD8 expression. Thus, we did additional bone marrow transplantation experiments with truncated forms of MAZR (MAZR truncations, Supplementary Fig. 4 online) to determine whether CD8 expression is directly or indirectly regulated by MAZR. None of the C-terminal truncations of MAZR resulted in variegated expression of CD8 (Fig. 8) , even though the truncated molecules retained their capacity to localize to the nucleus and were still able to bind N-CoR (data not shown). These data indicate that MAZR regulates CD8 expression directly by binding to the Cd8 loci.
DISCUSSION
The combined deletion of Cd8 enhancers E8 I and E8 II leads to variegated expression of CD8 in DP thymocytes 14 . Here we have demonstrated that CD8 variegation correlated with an epigenetic 'off' state of the Cd8a-Cd8b1 complex in cells that failed to express CD8, thus linking Cd8 enhancers to Cd8 loci-specific chromatinmodification pathways. We have further shown that the zinc finger protein MAZR interacts in DN thymocytes with CD8 enhancers and with N-CoR corepressor complexes. Expression of MAZR was downregulated during thymocyte development, and enforced expression of MAZR caused impaired activation and variegated expression of CD8 in DP thymocytes. Our results demonstrate epigenetic control of the Cd8 loci and identify MAZR as an important regulator of Cd8 expression. They also indicate that CD8 is actively repressed at the DN stage and that Cd8 enhancers can function either as negative or positive cis-acting elements by recruiting factors that block or facilitate chromatin modifications required for an epigenetic 'on' state. Combined deletion of E8 I and E8 II causes variegation of CD8 expression, resulting in the development of a subset of DP thymocytes that does not express CD8 (ref. 14). These CD8 -DP thymocytes had less histone H3 and H4 acetylation over the whole Cd8 loci. Furthermore, these cells had less H3K4 trimethylation and sustained DNA methylation at the Cd8a and Cd8b1 promoter region than did true DP thymocytes. Therefore, all of the epigenetic patterns analyzed indicate that the Cd8a-Cd8b1 complex is locked in an epigenetic 'off' state in CD8 -DP thymocytes. However, thymocytes that failed to activate the Cd8 loci because of deletion of cis-regulatory elements had not completely lost the potential to express CD8. Conditional deletion of Dnmt1 at the DN2 stage leads to a partial reactivation of CD8 expression and therefore to reduced CD8 variegation. Deletion of Dnmt1 at the DN2 stage is accompanied by demethylation of the Cd8 loci (but not induction of CD8 expression in T cell receptor ab-lineage DN cells) 19 . Thus, removal of negative epigenetic 'marks' such as DNA methylation at the Cd8 loci at the proper developmental stage can at least partially restore impaired CD8 expression in DP thymocytes. That observation emphasizes the need for Cd8 cis-regulatory elements to recruit factors that facilitate epigenetic modifications required for initiating CD8 expression. Differences in the epigenetic patterns resulting from the deletion of cis-regulatory elements at the Cd8 loci indicate that E8 I and E8 II (and probably other cis regions) recruit factors that induce activating chromatin modifications. These modifications alter the repressive state present in early-stage DN thymocytes, and therefore it was expected that factors that bind to Cd8 enhancers would positively influence the expression of CD8. However, the observation that enforced expression of MAZR caused variegation and therefore negatively influenced CD8 expression indicated a more complex regulatory activity for Cd8 cis-acting elements. Depending on the developmental stage, Cd8 enhancers recruit either negative or positive regulators of CD8 expression. Members of the BAF chromatinremodeling complex and the Ikaros gene family act as positive regulators 16, 18 . It has been suggested that Runx3 (recruited by E8 I ) is another positive factor required for CD8 expression after positive selection in CD8 SP thymocytes 32 . In contrast, MAZR seems to function as a negative regulator of CD8 expression in DN thymocytes. It is not known whether the same or distinct sites in these enhancers are required for the recruitment of positive or negative factors.
Chromatin immunoprecipitation assays have shown that MAZR interacts in vivo with several Cd8 enhancers in DN thymocytes. Multisite recruitment has also been noted for members of the Ikaros gene family. Several functional binding sites for Ikaros overlap with hypersensitivity sites in E8 I and E8 V (ref. 16 ). Thus, recruitment of either negative or positive regulatory factors to multiple sites in the Cd8a-Cd8b1 complex seems to ensure the proper and coordinated regulation of CD8 expression. To understand the complex regulatory pattern, it will be necessary to determine the developmental order of recruitment of MAZR and other factors by chromatin immunoprecipitation assay combined with Cd8 loci-specific DNA microarray analysis.
We have demonstrated here that MAZR interacted with N-CoR in a BTB domain-dependent way after overexpression in cell lines. More notably, this interaction also occurred in primary DN thymocytes. N-CoR and the related SMRT corepressor molecules are components of complexes containing proteins involved in epigenetic modifications of chromatin templates (such as Sin3A, NURD, SWI-SNF-like BAF and histone deacetylases), and N-CoR is recruited by several transcription factors 33 . Association with histone deacetylases has been suggested as being part of the mechanism of repression of transcription by N-CoR-interacting transcription factors. Thus, enhancermediated recruitment of MAZR and MAZR-N-CoR interactions may represent a molecular mechanism by which epigenetic modifications corresponding to a repressive state are introduced at the Cd8 loci in DN thymocytes. However, N-CoR-deficient mice have a block at the DN stage of thymocyte development 34 , indicating that absence of N-CoR alone is not sufficient to allow CD8 expression in DN thymocytes. Progression to the DP stage correlates with downmodulation of both N-CoR and MAZR, leading to a reduction in MAZR at the Cd8a-Cd8b1 complex, thus allowing positive regulators to overcome the repressive state and to activate CD8. If high concentrations of MAZR due to enforced expression are maintained, the balance between repressing and activating complexes at the Cd8 loci is disturbed, leading to variegated expression of CD8 and the appearance of CD8 -DP thymocytes. That hypothesis is supported by the observation that the degree of MAZR-induced CD8 variegation is increased in the absence of E8 I or E8 II , which also serve as recruitment sites for positive factors. Nevertheless, it could be argued that because of the large amounts of MAZR present after enforced expression, endogenous factors are sequestered from the Cd8 loci, thereby leading to CD8 variegation. However, we consider this scenario unlikely, as enforced expression of a form of MAZR lacking the C-terminal zinc fingers did not induce variegation. This truncated version retained a properly folded BTB domain that could bind N-CoR and localized to the nucleus and therefore, like the full-length form, should have been able to sequester endogenous factors from the Cd8 loci. Thus, these data, along with result from chromatin immunoprecipitation assays, indicate that MAZR acts directly at the Cd8a-Cd8b1 complex.
Finally, our results indicate active repression of CD8 expression in DN thymocytes. Recruitment of MAZR and N-CoR corepressor complexes via Cd8 enhancers may therefore prevent CD8 expression in DN cells. As premature transgenic expression of CD8 in DN2 and DN3 cells causes a partial developmental block, leading to reduced numbers of DP thymocytes 35 , active repression of CD8 expression by MAZR in DN thymocytes may be essential for b-selection and proper T cell development.
We propose that CD8 enhancers regulate CD8 expression by controlling the balance between closed and open state of chromatin at the Cd8 loci. Depending on the developmental stage, they recruit either negative or positive regulators of CD8 expression. MAZR seems to function as a negative regulator of CD8 expression in DN thymocytes. Therefore, the gradual downregulation of endogenous MAZR expression during thymocyte development may be a prerequisite for the proper initiation of CD8 expression.
METHODS
Cell lines and culture. HEK293T and Phoenix-E cell lines were grown in DMEM supplemented with 10% FCS and antibiotics.
Mice. C57BL/6J were purchased from Harlan-Winkelmann. 'Conditional LckCre-Tg Â Dnmt1 fl/fl mice' , E8 I -deficient and E8 II -deficient mice, and E8 I ,E8 II -KO Â Tcra -/-mice have been described 12, 14, 19 . All mice were bred and maintained in the animal facility of the Medical University of Vienna (Vienna, Austria). All animal experiments were done according to protocols approved by the Federal Ministry for Education, Science and Art (Vienna, Austria).
Bisulfite sequencing analysis. Bisulfite-based methylation analysis was done as described 19 . Samples were amplified by two sequential PCR reactions. Primers used have been described 19 or are listed in Supplementary Table 1 online. Gelpurified PCR products were cloned into the pCR2.1-TOPO TA cloning vector (Invitrogen), and 12 individual clones were sequenced for each group.
Chromatin immunoprecipitation. DP, CD8 -DP, or DN thymocytes (1 Â 10 7 cells; purity of each population, more than 90%) were treated with 0.3% formaldehyde in PBS for 5 min at 37 1C, followed by the addition of glycine (final concentration, 0.25 M). After being washed twice with PBS, cells were lysed on ice and were sonicated to obtain 0.5-to 1-kilobase sheared chromatin fragments. Subsequent chromatin immunoprecipitation steps were done according the protocol from Upstate Biotechnology. Each reaction included 5 ml antibody to acetylated H3 (anti-acetylated H3; 06-599; Upstate Biotechnology), 10 ml anti-acetylated H4 (06-866; Upstate Biotechnology), 8 ml antitrimethyl-H3K4 (07-473; Upstate Biotechnology), 3 ml anti-tri-methyl-H3K9 or anti-di-methyl-H3K9 (provided by T. Jenuwein, Research Institute of Molecular Pathology, Vienna, Austria) and 10 ml anti-MAZR rabbit serum or rabbit preimmune serum. The presence of DNA target sequences was assessed by PCR using the following conditions: 3 min at 95 1C, followed by 40 cycles of 30 s at 95 1C, 45 s at 58 1C and 1 min at 72 1C. PCR products were resolved by 2% agarose gel electrophoresis and were quantified with a Lumiimager analyzer and the Lumianalyst software package (Roche). Signal intensities at input dilutions of 1:3 were used for calculation of relative signal intensities for each amplicon. The relative values (arbitrary units) for each amplicon are presented below PCR blots in the figures and were calculated according a published method 32 as follows: (antibody precipitate intensity -mock precipitate intensity) / input intensity. Primers used for PCR are in Supplementary  Table 2 online. Retroviral constructs and virus production. Full-length or truncated forms of mouse MAZR were cloned into the MIG-R retroviral vector (provided by H. Singh, University of Chicago, Chicago, Illinois). High-titer viral preparations were generated by transient transfection of retroviral constructs into the ecotropic producer cell line Phoenix-E using standard calcium phosphate precipitation. Viral supernatants were collected 2 and 3 d after transfection, were filtered through 0.45-mm filters and were used for the infection of hematopoietic stem cells immediately after filtration.
Retroviral infection of hematopoietic stem cells. Transduction and transplantation of bone marrow cells was done according to published protocols 36 with minor modifications. C57BL/6J donor mice were injected intraperitoneally with 5-fluorouracil (Sigma) at 10 mg/ml 4 d before bone marrow collection. After red blood cell lysis, bone marrow cells were prestimulated for 24 h in DMEM (supplemented with 10% FCS, penicillin, streptomycin and L-glutamine) in the presence of recombinant mouse stem cell factor (5 U/ml), IL-6 (1 Â 10 4 U/ml) and IL-3 (6 U/ml; Peprotech).
For retroviral transduction, 1 Â 10 7 to 2 Â 10 7 activated bone marrow cells were transferred to a 10-cm non-tissue-culture-treated plate (Sterilin) precoated with RetroNectin (Takara). Infections were done according to the manufacturer's instructions by incubation for two to three 'rounds' with 7 ml viral supernatant supplemented with stem cell factor, IL-3 and IL-6 at the concentrations noted above. Bone marrow cells were collected 48 h after infection, were washed three times with PBS and were injected at a dose of 0.5 Â 10 6 to 3 Â 10 6 cells/mouse into the tail veins of lethally irradiated C57BL/6J recipient mice. The g-irradiation used a dose of 8.25 Gy and a Hille TH-150 instrument. Mice were given acidified drinking water supplemented with 25 mg/ml of neomycin and 25,000 U/ml of polymyxin B sulfate for 1 week.
Isolation of nuclear protein extracts. Nuclear protein extracts were prepared as described 37 . HEK293T cells (1 Â 10 7 ) were collected and were washed once with PBS. The cells were 'pelleted' (280g for 5 min) and were resuspended in 1 ml cold buffer A (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride, and protease inhibitors; Roche). After 10 min of incubation on ice, 50 ml of 10% Nonoidet-P40 was added and cells were lysed for an additional 10 min on ice. Nuclei were 'pelleted' (280g for 4 min) and were resuspended in 100 ml buffer C (20 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 420 mM NaCl, 25% glycerol, 0.2 mM EDTA, 0.5 mM dithiothreitol and 0.2 mM phenylmethylsulfonyl fluoride) for extraction of nuclear proteins. After 30 min of incubation on ice, the extract was 'pelleted' for 3 min at 4 1C at 16,000g in a microcentrifuge. The supernatant was 'snap-frozen' in liquid nitrogen and was stored at À80 1C until use.
Electrophoretic mobility-shift assay. Duplex oligonucleotides were labeled with T4 polynucleotide kinase and [g-32 P]ATP. Labeled oligonucleotides (2.5 Â 10 4 c.p.m.) were incubated in binding reaction buffer (10 mM TrisHCl, pH 7.5, 50 mM NaCl, 0.5 mM EDTA, 0.5 mM dithiothreitol, 1 mM MgCl 2 , 4% glycerol, 1 mg BSA and 1 mg poly(I)Ápoly(C)) with 10 mg nuclear protein extract isolated from HEK293T cells transfected with Myc-tagged MAZR construct. MAZR cDNA was cloned in-frame into an EcoRI restriction site of the pCDNA3-Myc plasmid (provided by R. de Martin, Medical University of Vienna, Vienna, Austria). Binding reactions were for 30 min at 30 1C in a total volume of 15 ml. For supershift experiments, 0.1, 0.5, 1 or 3 mg monoclonal antiMyc (OP10L; Calbiochem) was added to the reactions. Protein-DNA complexes were separated by 4% nondenaturing polyacrylamide/bisacrylamide (19:1, in 0.5Â TBE) gel electrophoresis at 10 mA for 2-3 h at 4 1C. The gel was then dried and was exposed to a Storage PhosphoImager Screen (Molecular Dynamics). A radiolabeled duplex oligonucleotide was used for electrophoretic mobility-shift assay (sequence of only one oligonucleotide strand: 5¢-AGGTGTGCTGCCCC CAGGTCCACCCGCAGGAGGAGAGGGGGCT-3¢).
Generation of a rabbit anti-MAZR serum. A MAZR fragment (corresponding to amino acids 146-293) was cloned into the pGEX-5X-1 vector and a glutathione S-transferase-MAZR fusion plasmid was transformed in Escherichia coli strain BL-21. A fusion protein of glutathione S-transferase and MAZR amino acids 146-293 (800 mg) was 'batch-purified' with glutathione-Sepharose 4B according to the manufacturer's instructions (Amersham Biosciences). The glutathione S-transferase fusion protein was used for rabbit immunization.
Flow cytometry and antibodies. Thymi were removed from mice and were placed into 60-mm tissue culture dishes containing staining buffer (PBS supplemented with 2% FCS and 0.1% sodium azide). Single-cell suspensions were made by passage of the tissue through a 70-mm nylon cell strainer. Cell suspensions were washed once with staining buffer, and 0.5 Â 10 5 to 5 Â 10 5 cells were incubated for 5 min on ice with Fc-block (Pharmingen) and then for 30 min with the appropriate antibodies. Then cells were washed once with staining buffer and analyzed or were incubated on ice for 30 min with secondary antibodies. The following antibodies were used for staining: phycoerythrinanti-mouse CD8a (CT-CD8a), tricolor-anti-mouse CD4 (CT-CD4), indodicarbocyanine-anti-mouse CD3e (500A2) and indodicarbocyanine-anti-mouse CD8a (CT-CD8a), from Caltag; and phycoerythrin-anti-mouse CD5 (53-7.3), from Pharmingen. Cells were analyzed with a FACSCalibur and Cellquest Pro software (Becton Dickinson).
Cell sorting. Thymocytes were stained with fluorescein isothiocyanate-anti-CD8, tricolor-anti-CD4 and phycoerythrin-anti-CD5 for sorting of CD4 -CD8 -(DN), CD4 + CD8 + (DP), CD4 + (CD4 SP) and CD8 + CD5 hi (CD8 SP) thymocyte subpopulations on a FACSAria (Becton Dickinson). For isolation of peripheral CD4 + or CD8 + T cells, splenocytes were treated briefly with red blood cell lysis buffer, were washed and were stained with fluorescein isothiocyanate-anti-CD4 or fluorescein isothiocyanate-anti-CD8, respectively. Then the cells were incubated with anti-fluorescein isothiocyanate magnetic beads (Miltenyi) and were purified to more than 97% purity over a MACS LS Column according to the manufacturer's instructions (Miltenyi).
Yeast one-hybrid screen. The Matchmaker One-Hybrid System was used according to the manufacturer's instructions (Clontech Laboratories) for yeast one-hybrid screening. Three tandem repeats of E8 II RE-1 were inserted into the pHISi-1 vector and were used as bait for screening for the interacting proteins. The cDNA expression library was cloned into pACT2 vector.
Synthesis of cDNA, RT-PCR and real-time quantitative PCR. Total RNA was isolated from sorted thymocyte subsets using TRIreagent (Sigma), and random hexamer and oligo-dT primers and SuperScript II reverse transcriptase (Invitrogen) were used according to the manufacturer's protocol for cDNA synthesis. Conditions for RT-PCR were 2 min at 95 1C, followed by 35 cycles of 30 s at 95 1C, 45 s at 60 1C and 1 min at 72 1C. SYBR green and the LightCycler detection system (Roche) were used for real-time quantitative PCR; these PCR conditions were 5 s at 95 1C, 5 s at 65 1C and 15 s at 72 1C for a total of 55 cycles. The following primers were used: for MAZR, 5¢-GCAGGTGCA CACTTCTGAGCGAC-3¢ and 5¢-GCATTTCTGGCCTTCTCGGTTACA-3¢; for hypoxanthine guanine phosphoribosyl transferase 1, 5¢-GATACAGGCCA GACTTTGTTG-3¢ and 5¢-GGTAGGCTGGCCTATAGGCT-3¢; and for Th-POK, 5¢-CACCTTCCACCTCTCTCTGGCTCGA-3¢ and 5¢-TTGCTTGGCGTG GTGTCCCA-3¢.
Generation of full-length MAZR and site-directed mutagenesis. Full-length Zfp278 cDNA (encoding 641 amino acids of MAZR) was generated by combining the Zfp278 cDNA sequence from the yeast one-hybrid screen clone (encoding 409 amino acids of MAZR) with a cDNA fragment encoding the C-terminal MAZR sequence. The Zfp278 3¢ cDNA sequence was amplified by PCR from thymocyte cDNA using 5¢-GCAGGTGCACACTTCTGAGCGAC-3¢ and 5¢-ACAGGTACCGAATTCGTCGACGGGACACAGCATGTCTCACTTC-3¢ as primers and was inserted as XhoI fragment into the Zfp278 yeast one-hybrid screen clone. The 'BTB MAZR ' and 'MAZRDZF' truncated forms of MAZR ( Supplementary Fig. 4 online) were amplified by PCR as XhoI fragments using Myc-tagged Zfp278 cDNA as template. The following primers were used: 5¢-AGACTCGAGGCTGCCACCATGGAACAAAAG-3¢ plus either 5¢-AGACTC GAGTCATTAAGATCTCGATGACCGAC-3¢ for BTB MAZR or 5¢-AGACTC GAGTCATTATGGAAGGATGCCTGC-3¢ for MAZRDZF. Mutations in the sequence encoding the BTB domain of MAZR (MAZR mut ) were introduced
